Brazilian pharma unit files for IPO

Brazilian pharma unit files for IPO

Blau Farmaceutica has requested permission from Brazil's securities regulator, CVM, to take the company public through an IPO. In a securities filing, the local biopharmaceutical company named Itau BBA, Morgan Stanley, JPMorgan and Banco Safra as underwriters of the equity offering. ECM sources said a potential offering was likely to materialize in 2018. Blau recorded net revenues of BRL492m ($151.4m) in the year-ended September, according to figures in the securities filing. For the year-ended

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial